CAI - Caris Life Sciences Inc.
19.79
-0.710 -3.588%
Share volume: 1,540,293
Last Updated: 04-23-2026
Healthcare/Services – Health:
0.05%
PREVIOUS CLOSE
CHG
CHG%
$20.50
-0.71
-0.03%
View ratios
| Fiscal Date | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q3 2025 | Q4 2025 | |
| Report Date | 11-05-2025 | 03-03-2026 | |
| Total revenue | 216.833 M | 0.000 | |
| Cost of revenue | 69.327 M | 0.000 | |
| Gross profit | 147.506 M | 0.000 | |
| -100.00% | |||
| Operating expenses | 73.597 M | 0.000 | |
| Selling general and admin | 51.973 M | 0.000 | |
| Research and development | 21.624 M | 0.000 | |
| Total expenses | 114.864 M | 0.000 | |
| -100.00% | |||
| Operating income | 32.642 M | 0.000 | |
| Ebit | 30.472 M | 0.000 | |
| Pretax income | 24.325 M | 0.000 | |
| -100.00% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | 24.325 M | 0.000 | |
| -100.00% |